Leukoencephalopathia, demyelinating peripheral neuropathy and dural ectasia explained by a not formerly described de novo mutation in the SAMD9L gene, ends 27 years of investigatio...

por Thunström, Sofia, Axelsson, Markus
Publicado 2019

Neuronal antibodies in adult patients with new‐onset seizures: A prospective study

por Zelano, Johan, Axelsson, Markus, Constantinescu, Radu, Malmeström, Clas, Kumlien, Eva
Publicado 2019

Decreased Incidence of Guillain-Barré Syndrome during the COVID-19 Pandemic: A Retrospective Population-Based Study

por Hafsteinsdóttir, Brynhildur, Dalemo, Ellen, Elíasdóttir, Ólöf, Ólafsson, Elías, Axelsson, Markus
Publicado 2023

Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based study

por Rosenstein, Igal, Axelsson, Markus, Novakova, Lenka, Blennow, Kaj, Zetterberg, Henrik, Lycke, Jan
Publicado 2021

Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing–remitting multiple sclerosis

por Rosenstein, Igal, Axelsson, Markus, Novakova, Lenka, Malmeström, Clas, Blennow, Kaj, Zetterberg, Henrik, Lycke, Jan
Publicado 2023

A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis

por Sandgren, Sofia, Novakova, Lenka, Nordin, Anna, Axelsson, Markus, Malmeström, Clas, Zetterberg, Henrik, Lycke, Jan
Publicado 2023

MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS)

por Jernås, Margareta, Malmeström, Clas, Axelsson, Markus, Nookaew, Intawat, Wadenvik, Hans, Lycke, Jan, Olsson, Bob
Publicado 2013

SARS‐COV‐2 a trigger of myelin oligodendrocyte glycoprotein‐associated disorder

por Johnsson, Magnus, Asztely, Fredrik, Hejnebo, Susanne, Axelsson, Markus, Malmeström, Clas, Olausson, Torbjörn, Lycke, Jan
Publicado 2022

Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis

por Rosenstein, Igal, Rasch, Sofia, Axelsson, Markus, Novakova, Lenka, Blennow, Kaj, Zetterberg, Henrik, Lycke, Jan
Publicado 2022

High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis

por Rosenstein, Igal, Axelsson, Markus, Novakova, Lenka, Rasch, Sofia, Blennow, Kaj, Zetterberg, Henrik, Lycke, Jan
Publicado 2023

No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab

por Johnsson, Magnus, Farman, Helen H, Blennow, Kaj, Zetterberg, Henrik, Malmeström, Clas, Axelsson, Markus, Lycke, Jan
Publicado 2022

The role of autoimmune antibodies to predict secondary autoimmunity in patients with relapsing-remitting multiple sclerosis treated with alemtuzumab: A nationwide prospective surve...

por Sandgren, Sofia, Novakova, Lenka, Axelsson, Markus, Amirbeagi, Firoozeh, Kockum, Ingrid, Olsson, Tomas, Malmestrom, Clas, Lycke, Jan
Publicado 2023

High Interferon-γ Uniquely in Vδ1 T Cells Correlates with Markers of Inflammation and Axonal Damage in Early Multiple Sclerosis

por Singh, Avadhesh Kumar, Novakova, Lenka, Axelsson, Markus, Malmeström, Clas, Zetterberg, Henrik, Lycke, Jan, Cardell, Susanna L.
Publicado 2017

Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers

por Novakova, Lenka, Axelsson, Markus, Malmeström, Clas, Imberg, Henrik, Elias, Olle, Zetterberg, Henrik, Nerman, Olle, Lycke, Jan
Publicado 2018

Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection

por Hermansson, Linn, Yilmaz, Aylin, Axelsson, Markus, Blennow, Kaj, Fuchs, Dietmar, Hagberg, Lars, Lycke, Jan, Zetterberg, Henrik, Gisslén, Magnus
Publicado 2019

Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis

por Sandelius, Åsa, Sandgren, Sofia, Axelsson, Markus, Malmeström, Clas, Novakova, Lenka, Kostanjevecki, Vesna, Vandijck, Manu, Blennow, Kaj, Zetterberg, Henrik, Lycke, Jan
Publicado 2019

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

por Novakova, Lenka, Zetterberg, Henrik, Sundström, Peter, Axelsson, Markus, Khademi, Mohsen, Gunnarsson, Martin, Malmeström, Clas, Svenningsson, Anders, Olsson, Tomas, Piehl, Fredrik, Blennow, Kaj, Lycke, Jan
Publicado 2017

Inflammation-related plasma and CSF biomarkers for multiple sclerosis

por Huang, Jesse, Khademi, Mohsen, Fugger, Lars, Lindhe, Örjan, Novakova, Lenka, Axelsson, Markus, Malmeström, Clas, Constantinescu, Clara, Lycke, Jan, Piehl, Fredrik, Olsson, Tomas, Kockum, Ingrid
Publicado 2020

Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study

por Zhukovsky, Christina, Sandgren, Sofia, Silfverberg, Thomas, Einarsdottir, Sigrun, Tolf, Andreas, Landtblom, Anne-Marie, Novakova, Lenka, Axelsson, Markus, Malmestrom, Clas, Cherif, Honar, Carlson, Kristina, Lycke, Jan, Burman, Joachim
Publicado 2021

Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy

por Salzer, Jonatan, Svenningsson, Rasmus, Alping, Peter, Novakova, Lenka, Björck, Anna, Fink, Katharina, Islam-Jakobsson, Protik, Malmeström, Clas, Axelsson, Markus, Vågberg, Mattias, Sundström, Peter, Lycke, Jan, Piehl, Fredrik, Svenningsson, Anders
Publicado 2016